Skip to search formSkip to main contentSkip to account menu

nipradilol

Known as: 2H-1-Benzopyran-3-ol, 3,4-dihydro-8-(2-hydroxy-3-((1-methylethyl)amino)propoxy)-, 3-nitrate, 3,4-dihydro-8-(2-hydroxy-3--isopropylaminopropoxy)-3-nitroxy-2H-1-benzopyran 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2002
Highly Cited
2002
Purpose. To determine whether nipradilol, a new antiglaucoma drug, can protect retinal ganglion cells (RGCs) from secondary cell… 
2002
2002
PurposeTo investigate effects of nipradilol, a nonselective &bgr;- andbgr;-and selective &agr;1-receptor antagonist and a… 
2001
2001
Purpose. To evaluate the role of nitric oxide (NO) in the mechanism of the ocular hypotensive action of nipradilol, a ß-blocker… 
2000
2000
AIMS To study the effects of topical nipradilol, a non-selective beta blocker with alpha blocking and nitroglycerin-like… 
1998
1998
PURPOSE To study the effects of nipradilol, a nonselective beta-blocker with alpha 1-blocking activity and nitroglycerin-like… 
1996
1996
The effects of nipradilol, an ocular hypotensive drug, on isolated canine retinal central arteries and on retinal arterioles in… 
1985
1985
Nipradilol competitively antagonized norepinephrine- or phenylephrine-induced contractile responses of guinea-pig thoracic aorta…